Bringing the fundamentals into focus…
Back to Edgewise Therapeutics, Inc.
How Edgewise Therapeutics, Inc. stacks up
EWTX · against 256 other Healthcare companies of similar size
Profitability
22/ 100
Near the bottom of its peers.
Ranked #209 of 257 · scores higher than 18% of peers
Bars: peers in each 10-point band of the profitability score23 peers with a profitability score of 20–29, including EWTX · Click a bar to see the companies
Why profitability scores 22?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 87% of peers. Return on invested capital: -46.0% vs peer median 4.7%
- a lower return on assets: weaker than 72% of peers. Return on assets: -6.2% vs peer median 1.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = EWTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | EWTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 248 reported | -46.0% | 8.2% | 9% | 33% | |
| Operating marginHigher is better · 234 reported | Not reported | 10.9% | — | — | 33% |
| Return on assetsHigher is better · 243 reported | -6.2% | 3.4% | 25% | 33% | |
| Return on equityHigher is better · 239 reported | -38.0% | 7.5% | 18% | Context only | |
| Gross marginHigher is better · 264 reported | 0.0% | 48.0% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around EWTX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 4 | 3.8B USD | 99 | 71 | |
| 206 | 5.6B USD | 25 | 53 | |
| 208 | 4.2B USD | 23 | 44 | |
| 209 | 34.9B CNY (≈$4.9B) | 22 | 16 | |
| 209 | 2.2B USD | 22 | 32 | |
| 209 | 4.1B USD | 22 | 42 | |
| 209 | 2.0B USD | 22 | 29 | |
| 213 | 7.3B USD | 21 | 32 | |
| 213 | 2.6B USD | 21 | 43 | |
| 213 | 2.8B USD | 21 | 22 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score